Q3 results 2026: BSE, Zydus Life, Aurobindo Pharma among 170 companies to declare earnings today; full list here

Q3 results 2026: Around 170 companies will kickstart the fifth week of Q3 earnings FY26 season by releasing their financial results for the quarter ending on December 31, 2025.

BSE, Zydus Lifesciences, Aurobindo Pharma, Bajaj Electricals, Bata India, Happiest Minds Technologies, Navin Fluorine International, P N Gadgil Jewellers, Sun Pharma, among companies to declare Q3 earnings FY26 today.

On Friday, the Indian stock market ended the session on a positive note, aided by buying in select heavyweight stocks after the Reserve Bank of India announced its policy decision. The Sensex climbed 266.47 points, or 0.32%, to close at 83,580.40, while the Nifty 50 gained 50.90 points, or 0.20%, to finish at 25,693.70.

Zydus Lifesciences Q3 results preview

Brokerage firm Motilal Oswal expects revenue to grow 20.9% YoY, driven by healthy performance in the base business and full quarter impact of acquisitions.

“US to deliver low single-digit growth of ~5.9% YoY, supported by new product launches. DF growth of ~11% YoY is expected, primarily driven by chronic therapies, including cardiac and respiratory therapies. Expansion of the Comfort Click franchise into additional markets will be a key monitorable,” the firm said.

Aurobindo Pharma Q3 results preview

Kotak Institutional Equities expect ARBP's ex-gRevlimid US sales to increase 4% quarter-to-quarter (QoQ) in 3QFY26.

“We expect US injectables sales to increase 2% qoq to US$93 mn. Accordingly, we bake in an overall US sales growth of 3% qoq to US$430 mn in the quarter. In EU, we factor in 12% yoy growth in 3QFY26, while for the ARV segment, we bake in 3% yoy sales decline. For the ROW markets, we forecast flat yoy sales growth in 3QFY26. Overall, we expect ARBP's revenues to grow 6% yoy (+2% qoq) in 3QFY26,” it said.

Bata India Q3 results preview

Motilal Oswal believes that the revenue growth will remain tepid at 2% YoY owing to weak consumer sentiment. Meanwhile, it anticipates EBITDA margin to expand by 80bp YoY, largely due to accounting changes for royalty.

“Expect Adj PAT to decline by 3% YoY due to operating deleverage,” the firm said.

Here's a list of companies to declare Q3 results 2026 today, Monday, February 9 -

Disclaimer: This story is for educational purposes only. Please consult with an investment advisor before making any investment decisions.